Teppei Okamoto
Papers
9
Total Citations
127
H-Index
6
About
Teppei Okamoto is a urologic surgeon and researcher whose work centers on the intersection of frailty, geriatric assessment, and surgical outcomes in prostate and bladder cancer. His major contributions include pioneering the use of the Geriatric 8 (G8) screening tool to evaluate frailty in prostate cancer patients, demonstrating that frailty predicts both surgical contraindications and postoperative pain after robot-assisted laparoscopic prostatectomy. His prospective studies—such as the FRART-PC and FRAP studies—have collectively garnered over 100 citations, establishing him as a leading voice in geriatric urologic oncology. Notably, his 2020 paper on G8 screening in prostate cancer (40 citations) has become a reference point for integrating frailty assessment into treatment decision-making. Okamoto has also explored novel biomarkers like cell-free DNA for evaluating surgical damage and has compared neoadjuvant chemohormonal therapy with extended lymph-node dissection in high-risk prostate cancer. His work extends to bladder cancer, where he has investigated robot-assisted radical cystectomy’s impact on peritoneal carcinomatosis. Through these contributions, Okamoto is shaping how surgeons tailor treatments for older, frailer patients, improving both oncologic and patient-reported outcomes.
Research Focus
Key Achievements
Top Papers
- 1Geriatric 8 screening of frailty in patients with prostate cancer40 citations · 2020
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9